Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update

Affiliations

¹ Gynaecologic Oncology, Imperial College London Faculty of Medicine, London, UK chfotopoulou@gmail.com.
² Department of Gynecology and Obstetrics, Innsbruck Medical Univeristy, Innsbruck, Austria.
³ Clinical Research Unit, Institut Bergonie, Bordeaux, France.
⁴ Institut Gustave-Roussy, Paris, Île-de-France, France.
⁵ Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, ImmunOvar Research Group, Katholieke Universiteit Leuven, Leuven, Belgium.
⁶ Department of Gynecology and Obstetrics, Leuven Cancer Institute, Katholieke Universiteit Leuven UZ Leuven, Leuven, Belgium.
⁷ Department of Gynecology and Gynecological Oncology, Kliniken Essen Mitte (KEM), Essen, Germany.
⁸ Surgery, Institut Bergonie, Bordeaux, France.

^# Contributed equally.

Free article

Christina Fotopoulou et al. Int J Gynecol Cancer. 2020 Apr.

Free article

. 2020 Apr;30(4):436-440.

doi: 10.1136/ijgc-2020-001248. Epub 2020 Feb 20.

¹ Gynaecologic Oncology, Imperial College London Faculty of Medicine, London, UK chfotopoulou@gmail.com.
² Department of Gynecology and Obstetrics, Innsbruck Medical Univeristy, Innsbruck, Austria.
³ Clinical Research Unit, Institut Bergonie, Bordeaux, France.
⁴ Institut Gustave-Roussy, Paris, Île-de-France, France.
⁵ Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, ImmunOvar Research Group, Katholieke Universiteit Leuven, Leuven, Belgium.
⁶ Department of Gynecology and Obstetrics, Leuven Cancer Institute, Katholieke Universiteit Leuven UZ Leuven, Leuven, Belgium.
⁷ Department of Gynecology and Gynecological Oncology, Kliniken Essen Mitte (KEM), Essen, Germany.
⁸ Surgery, Institut Bergonie, Bordeaux, France.

^# Contributed equally.

No abstract available

Keywords: ovarian cancer; surgical oncology.

Conflict of interest statement

Competing interests: None declared.